Nuveen
APYX icon

Nuveen’s Apyx Medical APYX Stock Holding History

Nuveen’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-85,991
Closed -$616K – 3246
2022
Q1 		$616K Hold
85,991
– – ﹤0.01% 2953
2021
Q4 		$1.06M Sell
85,991
-12,124
-12% -$170K ﹤0.01% 2840
2021
Q3 		$1.13M Sell
98,115
-5,134
-5% -$54K ﹤0.01% 2951
2021
Q2 		$1.06M Sell
103,249
-25,364
-20% -$251K ﹤0.01% 2981
2021
Q1 		$1.24M Sell
128,613
-19,012
-13% -$190K ﹤0.01% 2824
2020
Q4 		$1.06M Buy
147,625
+706
+0.5% +$4.68K ﹤0.01% 2783
2020
Q3 		$692K Buy
146,919
+25,038
+21% +$124K ﹤0.01% 2833
2020
Q2 		$676K Buy
121,881
+33,954
+39% +$141K ﹤0.01% 2789
2020
Q1 		$316K Sell
87,927
-115
-0.1% -$772 ﹤0.01% 2914
2019
Q4 		$745K Sell
88,042
-14,440
-14% -$104K ﹤0.01% 2793
2019
Q3 		$694K Buy
102,482
+16,040
+19% +$114K ﹤0.01% 2839
2019
Q2 		$580K Buy
+86,442
New +$470K ﹤0.01% 2958

Other funds holding APYX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
KLC
Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.89B AUM 151.53% 1-Year Est. Return
IP
Invenire Partners Ridgefield, Connecticut $65.4M AUM 18.1% 1-Year Est. Return

Nuveen's APYX Position: Q2 2022 in Review

Nuveen sold out of Apyx Medical (APYX) in Q2 2022, closing a stake of 85,991 shares — an estimated $616K sold.

Nuveen first reported a position in APYX in Q2 2019 and held it in 12 quarters. The position peaked at $1.24M in Q1 2021. 63 funds tracked by Wall St. Rank hold APYX as of Q2 2022.

  • Nuveen reported no remaining Apyx Medical position as of Q2 2022 after selling out during the quarter.
  • Nuveen sold 85,991 Apyx Medical shares in Q2 2022, an estimated $616K.
  • Nuveen first reported a position in Apyx Medical in Q2 2019 and held it in 12 quarters.
  • Nuveen's Apyx Medical position peaked at $1.24M in Q1 2021.
  • 63 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2022.

Based on Nuveen's 13F filing for Q2 2022, filed 15 Aug 2022.